On June 30, Albemarle rose 6.36% in regular trading, trading at approximately $136.52/share, with turnover of $30.77 million. The rebound comes after the stock plunged over 15% from approximately $157 to $134 in the prior week amid broad lithium sector weakness.

On the news front, Jefferies adjusted its target price on Albemarle from $244 to $211 while maintaining a Buy rating, implying roughly 55% upside from current levels. According to FactSet, the analyst consensus target price stands at $218.37, with Citi, RBC, UBS, and other major institutions maintaining buy or outperform ratings, with targets concentrated in the $211 to $264 range — all significantly above the current stock price. The sharp prior-week selloff and sustained institutional bullishness suggest the current move carries characteristics of an oversold technical recovery.

Within the Specialty Chemicals sector, Sociedad Quimica Y Minera De Chile SA up 4.45%, Element Solutions up 1.45%, Balchem up 0.41%, Ecolab up 0.27%, Sherwin-Williams down 0.83%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)